129 - Clinical Controversies in S. aureus Bacteremia Management and Prevention

Speaker(s)

• 

  Sara Cosgrove, MD, MS

  Professor of Medicine
  Johns Hopkins University School of Medicine
  Baltimore, MD

  Disclosure: Basilea () : Consultant; Theravance () : Consultant
• 

  Susan Huang, MD, MPH

  Professor
  Division of Infectious Diseases
  University of California, Irvine
  Irvine, CA

  Disclosure: Medline : Conducted clinical trials and studies in which participating hospitals and nursing homes received contributed antiseptic product (Status: Ongoing), Other Financial or Material Support (Status: Ongoing); Molnlycke : Conducted clinical trials and studies in which participating hospitals and nursing homes received contributed antiseptic product (Status: Terminated --- Feb 2016), Other Financial or Material Support (Status: Terminated --- Feb 2016); Stryker (Sage) : Conducted clinical trials and studies in which participating hospitals and nursing homes received contributed antiseptic product (Status: Terminated --- June 2019), Other Financial or Material Support (Status: Terminated --- June 2019); Xttrium : Conducted clinical trials and studies in which participating hospitals and nursing homes received contributed antiseptic product (Status: Terminated --- June 2019), Other Financial or Material Support (Status: Terminated --- June 2019)
• 

  Susan Rehm, MD

  Vice Chair, Department of Infectious Disease
  Cleveland Clinic
  Cleveland , Ohio

  Disclosure: Merck () : Shareholder; Pfizer () : Shareholder

CME Credits: Maximum of 1.75 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.75 hours of MOC Credit
ACPE Credits: ACPE 1.75 Knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-20-498-L01-P

Learning Objectives:

• describe the optimal diagnostic evaluation for a patient with S. aureus bacteremia
• analyze the role of combination therapy for S. aureus bacteremia
• discuss optimal prevention strategies for S. aureus bacteremia

Presentations:

• 1:15pm – 3:00pm EDT

  Combination Therapy for SAB: Who, What, When
  Sara E. Cosgrove, MD, MS – Johns Hopkins University School of Medicine
• 1:15pm – 3:00pm EDT

  Decolonization as a S. aureus Bacteremia Prevention Strategy
  Susan S. Huang, MD, MPH – University of California, Irvine
• 1:15pm – 3:00pm EDT

  Diagnostic Evaluation for S. aureus Bacteremia: To TEE or Not to TEE, and Other Burning Questions
  Susan J. Rehm, MD – Cleveland Clinic